Corrigendum: ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity

Front Immunol. 2024 Feb 29:15:1385729. doi: 10.3389/fimmu.2024.1385729. eCollection 2024.

¹ Institute for Virology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
² University of Bonn, Faculty of Mathematics and Natural Sciences, Life & Medical Sciences (LIMES) Institute, Bonn, Rheinland-Pfalz, Germany.
³ Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Rheinland-Pfalz, Germany.
⁴ Helmholtz Institute for Translational Oncology (HI-TRON) Mainz, Mainz, Rheinland-Pfalz, Germany.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1335302.].

Keywords: E6 E7 oncogene expression; ErbB2; HER2/neu; HPV16; human papillomavirus; promoter activity; tucatinib; tyrosine kinase inhibitor.